SCOPIA CAPITAL MANAGEMENT LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 198 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCOPIA CAPITAL MANAGEMENT LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$7,961,000
-68.8%
2,773,777
-16.5%
0.47%
-58.8%
Q2 2019$25,491,000
-57.0%
3,323,456
-25.5%
1.13%
-48.3%
Q1 2019$59,274,000
-30.7%
4,460,073
-18.8%
2.19%
-24.6%
Q4 2018$85,550,000
-38.7%
5,491,035
-22.7%
2.90%
+8.0%
Q3 2018$139,652,000
-36.3%
7,106,955
-6.9%
2.69%
-29.8%
Q2 2018$219,169,000
+9.4%
7,636,566
-9.9%
3.83%
-4.5%
Q1 2018$200,427,000
+10.3%
8,474,7280.0%4.01%
+23.0%
Q4 2017$181,783,000
-9.3%
8,474,7280.0%3.26%
+2.9%
Q3 2017$200,427,000
+40.8%
8,474,728
+17.3%
3.17%
+8.0%
Q2 2017$142,311,000
+21.7%
7,223,906
+29.7%
2.94%
+35.9%
Q1 2017$116,934,000
+37.2%
5,568,306
+22.9%
2.16%
+33.8%
Q4 2016$85,203,000
-2.9%
4,532,067
+7.8%
1.61%
+4.3%
Q3 2016$87,780,000
+8.5%
4,204,006
+32.6%
1.55%
-7.3%
Q2 2016$80,882,000
+15.2%
3,171,229
+19.4%
1.67%
+27.5%
Q1 2016$70,239,000
-15.9%
2,655,533
+35.9%
1.31%
-21.0%
Q4 2015$83,567,000
+455.7%
1,953,423
+244.3%
1.66%
+413.3%
Q3 2015$15,039,000567,2980.32%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders